The Endocannabinoid System and Oligodendrocytes in Health and Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Endocannabinoid System and Oligodendrocytes in Health and Disease
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-10-26
DOI
10.3389/fnins.2018.00733
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oligodendrogenesis after traumatic brain injury
- (2018) Hajime Takase et al. BEHAVIOURAL BRAIN RESEARCH
- Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence
- (2018) Emily Stockings et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
- (2018) Valerio Chiurchiù et al. PROGRESS IN NEUROBIOLOGY
- Myelination and mTOR
- (2017) Gianluca Figlia et al. GLIA
- Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy
- (2017) Ana Beatriz DePaula-Silva et al. JOURNAL OF NEUROIMMUNOLOGY
- 2-arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination
- (2017) A Feliu et al. JOURNAL OF NEUROSCIENCE
- White Matter Plasticity in the Adult Brain
- (2017) Cassandra Sampaio-Baptista et al. NEURON
- Chronic demyelination-induced seizures
- (2017) Andrew S. Lapato et al. NEUROSCIENCE
- Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation
- (2017) Sabrina Giacoppo et al. Multiple Sclerosis and Related Disorders
- Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
- (2017) Attila Oláh et al. Frontiers in Immunology
- The heterogeneous nature of NG2-glia
- (2016) F. Viganò et al. BRAIN RESEARCH
- Lineage, fate, and fate potential of NG2-glia
- (2016) Akiko Nishiyama et al. BRAIN RESEARCH
- The reactions and role of NG2 glia in spinal cord injury
- (2016) Joel Levine BRAIN RESEARCH
- The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte DifferentiationIn Vitroand Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination
- (2016) Jordi Tomas-Roig et al. CNS Neuroscience & Therapeutics
- White matter involvement after TBI: Clues to axon and myelin repair capacity
- (2016) Regina C. Armstrong et al. EXPERIMENTAL NEUROLOGY
- Function of neural stem cells in ischemic brain repair processes
- (2016) Ruilan Zhang et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury
- (2016) Arsalan Alizadeh et al. JOURNAL OF PHYSIOLOGY-LONDON
- Glutamate signalling: A multifaceted modulator of oligodendrocyte lineage cells in health and disease
- (2016) Sonia Spitzer et al. NEUROPHARMACOLOGY
- The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination
- (2016) David Gonsalvez et al. NEUROPHARMACOLOGY
- Cannabinoids to treat spinal cord injury
- (2016) Angel Arevalo-Martin et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
- (2016) Angélica Pupin Schiavon et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage
- (2016) Carla Marinelli et al. Frontiers in Cellular Neuroscience
- Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
- (2015) Sumner Burstein BIOORGANIC & MEDICINAL CHEMISTRY
- Endocannabinoids drive the acquisition of an alternative phenotype in microglia
- (2015) M. Mecha et al. BRAIN BEHAVIOR AND IMMUNITY
- NG2-glia and their functions in the central nervous system
- (2015) L. Dimou et al. GLIA
- Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
- (2015) Valerio Chiurchiù et al. Journal of Neuroimmune Pharmacology
- A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways
- (2015) Oscar Gomez et al. Journal of Neuroimmune Pharmacology
- Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
- (2015) Benjamin Ettle et al. MOLECULAR NEUROBIOLOGY
- Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis
- (2015) Jie Wen et al. NEUROPHARMACOLOGY
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- Cannabinoids in the Treatment of Epilepsy
- (2015) Daniel Friedman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oligodendrocytes in a Nutshell
- (2015) John-Paul Michalski et al. Frontiers in Cellular Neuroscience
- Oligodendrocytes: Myelination and Axonal Support
- (2015) Mikael Simons et al. Cold Spring Harbor Perspectives in Biology
- The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors
- (2015) Miguel Moreno-Martet et al. Multiple Sclerosis and Related Disorders
- A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis
- (2015) Sabrina Giacoppo et al. DARU-Journal of Pharmaceutical Sciences
- Inflammation in Ischemic Stroke: Mechanisms, Consequences and Possible Drug Targets
- (2014) Muzamil Ahmad et al. CNS & Neurological Disorders-Drug Targets
- Oligodendrocyte Pathophysiology and Treatment Strategies in Cerebral Ischemia
- (2014) Gabriella Mifsud et al. CNS Neuroscience & Therapeutics
- Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP3 Inflammasome
- (2014) Bo-Zong Shao et al. CNS Neuroscience & Therapeutics
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats
- (2014) Marco Bortolato et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelinationin vivo
- (2014) Ana Bernal-Chico et al. GLIA
- Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids
- (2014) Gareth Pryce et al. Journal of Neuroimmune Pharmacology
- Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases
- (2014) Hugo González et al. JOURNAL OF NEUROIMMUNOLOGY
- The early development of brain white matter: A review of imaging studies in fetuses, newborns and infants
- (2014) J. Dubois et al. NEUROSCIENCE
- A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
- (2014) Francisco J. Carrillo-Salinas et al. PLoS One
- Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS
- (2013) N Murataeva et al. BRITISH JOURNAL OF PHARMACOLOGY
- The role of myelin and oligodendrocytes in axonal energy metabolism
- (2013) Aiman S Saab et al. CURRENT OPINION IN NEUROBIOLOGY
- TRPV1 antagonist capsazepine suppresses 4-AP-induced epileptiform activity in vitro and electrographic seizures in vivo
- (2013) Luis E. Gonzalez-Reyes et al. EXPERIMENTAL NEUROLOGY
- Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
- (2013) Slava Rom et al. Journal of Neuroimmune Pharmacology
- M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
- (2013) Veronique E Miron et al. NATURE NEUROSCIENCE
- Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain
- (2013) Ethan G Hughes et al. NATURE NEUROSCIENCE
- Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis
- (2013) R. Ribeiro et al. NEUROSCIENCE
- Mechanisms regulating the development of oligodendrocytes and central nervous system myelin
- (2013) S. Mitew et al. NEUROSCIENCE
- Oligodendrogenesis after cerebral ischemia
- (2013) Ruilan Zhang et al. Frontiers in Cellular Neuroscience
- WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats
- (2012) Jing Sun et al. ACTA PHARMACOLOGICA SINICA
- WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination
- (2012) Jing Sun et al. BRAIN RESEARCH
- Microglia and neurodegeneration: The role of systemic inflammation
- (2012) Colm Cunningham GLIA
- Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery
- (2012) Angel Arevalo-Martin et al. PLoS One
- Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
- (2012) M Mecha et al. Cell Death & Disease
- Pathology of Demyelinating Diseases
- (2011) Bogdan F.Gh. Popescu et al. Annual Review of Pathology-Mechanisms of Disease
- Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways
- (2011) O Gomez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuroprotective agents: Cannabinoids
- (2011) A.J. Sánchez et al. CLINICAL IMMUNOLOGY
- Desensitization of Transient Receptor Potential Ankyrin 1 (TRPA1) by the TRP Vanilloid 1-Selective Cannabinoid Arachidonoyl-2 Chloroethanolamine
- (2011) N. B. Ruparel et al. MOLECULAR PHARMACOLOGY
- Cells of the oligodendroglial lineage, myelination, and remyelination
- (2010) Veronique E. Miron et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- NG2 cells: Properties, progeny and origin
- (2010) Jacqueline Trotter et al. BRAIN RESEARCH REVIEWS
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin
- (2010) G. Anderson et al. EUROPEAN JOURNAL OF NEUROLOGY
- A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats
- (2010) Marylou V. Solbrig et al. EXPERIMENTAL NEUROLOGY
- Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes
- (2010) Susana Mato et al. GLIA
- The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation
- (2010) Oscar Gomez et al. GLIA
- Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
- (2010) Derick T Wade et al. Multiple Sclerosis Journal
- The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
- (2010) William R Marrs et al. NATURE NEUROSCIENCE
- The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury
- (2010) Angel Arevalo-Martin et al. NEUROBIOLOGY OF DISEASE
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- The Cannabinoid WIN55212-2 Promotes Neural Repair After Neonatal Hypoxia–Ischemia
- (2010) David Fernández-López et al. STROKE
- Seizures in multiple sclerosis
- (2008) Marcus Koch et al. EPILEPSIA
- CB1cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes
- (2008) Susana Mato et al. GLIA
- The life, death, and replacement of oligodendrocytes in the adult CNS
- (2008) Dana M. McTigue et al. JOURNAL OF NEUROCHEMISTRY
- A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner
- (2008) Maria Beatriz Goncalves et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- The endocannabinoid system is modulated in response to spinal cord injury in rats
- (2008) Daniel Garcia-Ovejero et al. NEUROBIOLOGY OF DISEASE
- CB2cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies
- (2007) Arévalo-Martín et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB2receptors in the brain: role in central immune function
- (2007) G A Cabral et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage
- (2006) Basma Shouman et al. BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now